SCHEMBL29987435

SCHEMBL29987435

Fc1c(C(F)F)ccc2cnccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IMPDH2 P12268 4/20 0.41
▸ P4HB P07237 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MAPKAPK2 P49137 1/20 0.39
▸ ERN1 O75460 1/20 0.38
▸ HTT P42858 3/20 0.36
▸ CDK4 P11802 1/20 0.36
▸ CCND1 P24385 1/20 0.36
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14134353 0.84 HTR2A (0.40) IMPDH2P4HBKDM4ELMNACYP1A2
SCHEMBL29986726 0.76 IMPDH2 (0.46) IMPDH2P4HBKDM4ELMNACYP1A2
SCHEMBL29987113 0.76 KDM4E (0.53) IMPDH2KDM4ELMNACYP1A2CYP3A4
SCHEMBL13075204 0.73 IMPDH2 (0.43) IMPDH2KDM4ELMNACYP1A2CYP3A4
SCHEMBL19641735 0.73 IMPDH2 (0.52) IMPDH2P4HBKDM4ELMNACYP1A2
SCHEMBL445595 0.72 IMPDH2 (0.58) IMPDH2KDM4ELMNACYP1A2CYP3A4
SCHEMBL29523066 0.70 AXL (0.39) IMPDH2HTTMAPTPIM1CHUK
SCHEMBL22787654 0.70 AXL (0.39) IMPDH2HTTMAPTPIM1CHUK
Bromide SCHEMBL27922950 0.70 IMPDH2 (0.56) IMPDH2KDM4ELMNACYP1A2CYP3A4
SCHEMBL9883140 0.69 IMPDH2 (0.40) IMPDH2KDM4ELMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3980417-B1 PRMT5 INHIBITORS LUPIN LTD (IN) 2023-09-27 — — EP disclosed
US-20220315589-A1 PRMT5 INHIBITORS LUPIN LIMITED (IN) 2022-10-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315589-A1 PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 IMPDH2 350/4885P4HB 4564/4885KDM4E 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback